NPC B.Pharm common mistakes
NPC B.Pharm · Understand the traps and how to avoid them.
Quoting the Drug Act 2035 or its Regulations as if they were the NPC Act, and citing a section number that actually belongs to the other instrument when answering questions on registration, import, or licensing of narcotics.
Nepal's narcotics framework sits on two instruments - the Narcotic Drugs (Control) Act 2035 and the Narcotic Drugs (Control) Rules 2037 - while pharmacy practice, drug registration, and quality control sit on the Drugs Act 2035 and Drugs Rules 2037. Candidates study them together, both are dated 2035, and both use similar section numbering, so the citation gets attached to the wrong statute under time pressure.
What to do instead
Keep a two-column table in your notes: left column 'Narcotic Drugs (Control) Act 2035 / Rules 2037', right column 'Drugs Act 2035 / Drugs Rules 2037'. Under each, list only the section numbers you can verify from the statute text, and write one exam-style sentence per section. Before answering any citation question, ask yourself which instrument creates the offence or the licence being described. If you cannot recall the exact section number, answer with the instrument name and the substance of the provision rather than inventing a number.
Treating the Nepal Pharmacy Council's registration and ethics provisions as interchangeable with DDA licensing requirements, so a question about who may dispense or operate a retail pharmacy gets answered with a DDA licence number or vice versa.
Two regulators appear throughout the syllabus - the Department of Drug Administration for product registration, manufacturing and sale licences, and the Nepal Pharmacy Council for practitioner registration and professional conduct. Candidates memorise both lists separately but never map which regulator answers which question type, so the labels swap in the exam hall.
What to do instead
Build a one-page 'who does what' grid with rows for: registering a product, licensing a manufacturer, licensing a retail or wholesale seller, registering a pharmacist, disciplinary action against a pharmacist, and inspecting premises. Fill each cell with the responsible body and the instrument it acts under. Then practise ten short scenarios and, for each, write only the regulator and the legal basis before writing the full answer.
Describing a dissolution specification or a pharmacopoeial limit as a single number (for example 'not less than 80% in 45 minutes') without stating the apparatus, medium, volume, and stage structure the monograph actually specifies.
Candidates revise dissolution as a memorised percentage because that is the easiest fragment to recall, and monographs present the conditions in a dense table that is easy to skim. The result is an answer that is numerically plausible but technically incomplete, which loses marks in a question asking for the full test conditions.
What to do instead
For each dissolution-controlled product you revise, write the full condition set in a fixed order: apparatus number, medium composition and volume, temperature, rotation or flow rate, sampling times, and the Q value with its stage (S1, S2, S3) acceptance rules. Learn one immediate-release and one extended-release example completely rather than ten partially, and always reproduce the stage structure rather than a bare percentage.
Calculating a buffer or stability answer correctly but reporting it with the wrong significant figures, units, or without converting between molarity, percentage w/v, and mg/mL before substituting into the equation.
Pharmaceutical analysis and compounding calculations are usually attempted last, under time pressure, and candidates jump to the formula before normalising units. Percentage w/v and mg/mL differ by a factor of ten, and a missed conversion produces an answer that looks reasonable and is wrong by an order of magnitude.
What to do instead
Adopt a mandatory three-line working: line one states every given quantity with its unit converted to a single base (grams and litres, or moles and litres); line two writes the formula symbolically; line three substitutes and carries units through to the answer. Do twenty conversion drills mixing % w/v, % w/w, mg/mL, ppm, and molarity until the conversion step is automatic, and always state units in the final answer.
Answering pharmacokinetic questions by reciting half-life and clearance definitions instead of applying the equation - for example computing a loading dose from total body weight when the question gives volume of distribution and target concentration, or ignoring salt factor and bioavailability.
Definitions are what candidates rehearse, but exam questions give a clinical scenario and expect the arithmetic. Under time pressure the familiar formula (mg/kg × weight) is grabbed even when the data provided point to a different relationship, and the F and S factors are dropped because they were never practised inside a calculation.
What to do instead
Write out the core equations on one card: loading dose = (Vd × target concentration)/(F × S); maintenance rate = (CL × target concentration)/(F × S); and the relationship between half-life, Vd, and clearance. For each, solve three numeric problems using only the variables the question supplies, and explicitly state the value of F and S you assumed. Practise identifying which variables are given before choosing an equation.
Giving a therapeutic recommendation that names the right drug class but omits the monitoring parameter, the contraindication check, and the duration or stopping rule that the scenario is testing.
Clinical pharmacy questions are written as short patient vignettes, and candidates recognise the diagnosis and stop at the drug name. The marks are distributed across monitoring, contraindications, and follow-up, so a correct drug with no monitoring plan scores poorly.
What to do instead
Answer every therapeutic scenario with a fixed four-part template: (1) goal of therapy, (2) drug choice with dose and route, (3) monitoring parameters with timing, (4) contraindications and stop criteria. Rehearse this template on five common conditions - hypertension, type 2 diabetes, asthma, peptic ulcer disease, and a bacterial infection - until the four parts come out in order without prompting.
Describing a dosage form's manufacturing route in the wrong order, or omitting the unit operation that explains the property being asked about - for example explaining tablet hardness without mentioning compression force or binder concentration.
Candidates learn processes as lists of equipment rather than as cause-and-effect chains, so when a question asks why a defect occurs, they name the machine rather than the variable. Exam questions on capping, lamination, or content uniformity are testing the link between a process parameter and a quality attribute.
What to do instead
For each major dosage form, draw a flow diagram with the critical process parameter written beside each step and the quality attribute it controls. For tablets, link granulation method and binder level to flow and compressibility, and compression force and speed to hardness and capping. When answering a defect question, always name the parameter, the direction of change, and the resulting attribute.
Writing a study-guide or essay answer on GMP or quality assurance that lists principles in general terms without naming the specific requirement - for example saying 'adequate documentation' rather than stating what a batch record must contain or what a deviation report must capture.
Quality assurance is taught as a set of headings, and candidates reproduce the headings because they feel safe. Marking schemes reward the operational detail, so the answer reads as fluent but contains nothing that could be checked.
What to do instead
Convert every QA heading into at least three checkable specifics: for documentation, batch record contents, retention period, and who signs; for deviations, what is recorded, who investigates, and what triggers a recall. Write each answer as if briefing a new production officer who must act on it tomorrow, and delete any sentence that could apply to any industry.
Confusing pharmacopoeial identification tests with assay methods, so an IR spectroscopy or thin-layer chromatography identification limit is presented as a potency specification, or a titrimetric assay is described as confirming identity.
Both appear in the same monograph and both involve the same instrument in some cases, so the purpose of the test gets lost. Candidates also conflate limit tests for impurities with assay, which changes what the acceptance criterion means.
What to do instead
Classify every monograph test under one of four headings - identification, limit test for impurities, assay, or general quality (appearance, pH, loss on drying) - and write the acceptance criterion in the form the monograph uses. For each technique, state in one sentence what it proves: identity, absence of excess impurity, or quantity of active. Test yourself by naming the category before naming the method.
Answering a question on drug scheduling or prescription requirements using the classification from another country, or assuming a controlled substance can be dispensed on an ordinary prescription without checking the additional record-keeping requirement.
Much of the study material available online is written for other jurisdictions, and the schedules, prescription validity periods, and register requirements differ. Candidates absorb the foreign framework without noticing the mismatch, then apply it to a Nepal-specific question.
What to do instead
Keep a single reference sheet built only from the Nepali instruments, listing each category of controlled drug, who may prescribe it, the prescription validity, the record-keeping obligation, and the storage requirement. Where you cannot verify a detail from the statute, mark it as unverified and revise it from the primary text rather than from secondary summaries. Before answering, check whether the question is asking about legal classification or clinical use.